February 27, 2020 / 12:48 PM / a month ago

BRIEF-Jounce Therapeutics Reports Q4 Loss Per Share $0.68

Feb 27 (Reuters) - Jounce Therapeutics Inc:

* JOUNCE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.68

* Q4 EARNINGS PER SHARE ESTIMATE $-0.28 — REFINITIV IBES DATA

* JOUNCE THERAPEUTICS - EXPECTS GROSS CASH BURN ON OPERATING EXPENSES AND CAPITAL EXPENDITURES FOR 2020 TO BE ABOUT $80.0 MILLION TO $95.0 MILLION

* JOUNCE THERAPEUTICS - SEES EXISTING CASH, CASH EQUIVALENTS AND INVESTMENTS TO BE SUFFICIENT TO ENABLE FUNDING REQUIREMENTS THROUGH END OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below